ARTIVION, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ARTIVION, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $298.84M | Feb 22, 2022 |
| FY2021 | Dec 31, 2020 | $253.23M | Feb 22, 2022 |
| FY2019 | Dec 31, 2019 | $69.70M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $67.88M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $71.14M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $67.51M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $67.80M | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | $64.60M | Feb 19, 2020 |
| FY2019 | Jun 30, 2018 | $68.50M | Feb 19, 2020 |
| FY2019 | Mar 31, 2018 | $61.95M | Feb 19, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $441.33M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $388.54M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $354.00M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $313.79M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $298.84M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $253.23M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $276.22M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $262.84M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $189.70M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $180.38M | Feb 26, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $32.80M | Feb 15, 2013 |
| FY2012 | Sep 30, 2012 | $33.43M | Feb 15, 2013 |
| FY2012 | Jun 30, 2012 | $33.19M | Feb 15, 2013 |
| FY2012 | Mar 31, 2012 | $32.30M | Feb 15, 2013 |
| FY2012 | Dec 31, 2011 | $30.40M | Feb 15, 2013 |
| FY2012 | Sep 30, 2011 | $29.65M | Feb 15, 2013 |
| FY2012 | Jun 30, 2011 | $29.38M | Feb 15, 2013 |
| FY2012 | Mar 31, 2011 | $30.20M | Feb 15, 2013 |
| FY2012 | Dec 31, 2010 | $29.22M | Feb 15, 2013 |
| FY2012 | Sep 30, 2010 | $28.44M | Feb 15, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $284.23M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $248.78M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $229.18M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $202.52M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $197.51M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $167.78M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $46.55M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $45.22M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $46.97M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $44.27M | Feb 19, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.77M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($13.36M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | ($30.69M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($19.19M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($14.83M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | ($16.68M) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | ($681.0K) | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | ($134.0K) | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $2.83M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | ($297.0K) | Feb 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.75M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $38.87M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $5.74M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $6.20M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $8.12M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.44M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $17.04M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $9.31M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $7.97M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $21.82M | Feb 26, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $30.99M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $28.45M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $28.71M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $38.88M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $35.55M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $24.21M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $22.96M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $23.10M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $19.46M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $13.45M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $226.49M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $181.46M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $208.98M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $157.44M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $169.77M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $141.14M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $143.01M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $140.57M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $101.21M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $91.55M | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.88M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $22.24M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $18.83M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($5.15M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | ($2.59M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $12.37M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $15.83M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $9.88M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $10.80M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $19.72M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.04M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $11.19M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $9.75M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $10.72M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $13.09M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $7.33M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $8.07M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $5.79M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $6.63M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $6.20M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $884.80M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $789.10M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $792.40M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $762.80M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $793.05M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $789.40M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $605.65M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $571.09M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $589.69M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $316.14M | Mar 9, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $436.56M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $512.90M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $510.62M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $478.47M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $492.32M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $460.69M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $319.96M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $296.02M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $312.64M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $107.16M | Mar 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $448.23M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $276.20M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $281.78M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $284.33M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $300.73M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $328.71M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $285.70M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $275.07M | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $277.06M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $208.98M | Feb 19, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $254.09M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $240.96M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $247.34M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $243.63M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $250.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $260.06M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $186.70M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $188.78M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $188.31M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $78.29M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($51.50M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($61.27M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | ($47.91M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($17.22M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.98M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $20.02M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $36.70M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $34.98M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $37.61M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $34.14M | Mar 9, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.91M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $53.46M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $58.94M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $39.35M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $55.01M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $61.41M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $33.77M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $41.49M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $39.98M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $56.64M | Mar 9, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.11M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $314.35M | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $306.98M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $308.11M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $309.12M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $291.66M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $215.74M | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $216.88M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $218.95M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $71.57M | Mar 9, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 26, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 19, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2015 | $3.41M | Mar 9, 2018 |
| FY2016 | Dec 31, 2014 | $3.30M | Feb 16, 2017 |